- Display 15 Products per page
Published: November 21, 2017 | Price: $3,600.00 – $7,200.00
Next-Generation Sequencing Trends: Kalorama Survey of Laboratories Next-Generation Sequencing Trends: Kalorama Survey of Laboratories identifies some of the key changes taking place with both next-generation sequencing (NGS) systems in relation to their usage in labs and in relation to the sequencing of clinical samples for diagnostic or clinical research purposes. The report surveys the following aspects of NGS systems: system installations; sequencer applications, clinical applications, and usage trends; preferences and evaluations; and future purchase plans. This survey – of 78...Published: July 7, 2017 | Price: $3,360.00 – $5,040.00
The Worldwide Market for Liquid Biopsy This report covers the market for liquid biopsy, including cfDNA, CTC and other technologies. The market data in this report is segmented by those technologies type of cancer tested and by purpose - testing, screening, drug monitoring. Companies are profiled and the top ten companies are ranked and their recent activities detailed. Companies covered Include: cfDNA-based Liquid Biopsy Adaptive Biotechnologies Biodesix Epigenomics Foundation Medicine Genomic Health Guardant Health Myriad Genetics Pathway Genomics Personal Genome...Published: January 3, 2017 | Price: $3,600.00 – $7,200.00
The Market for Mass Spectrometry in Clinical Testing Applications The Market for Mass Spectrometry in Clinical Testing Applications covers the global opportunity for mass spectrometry instruments and consumables, including mass spectrometry revenues for 2016 and 2021, regional markets for 2016 and 2021 (North America, Europe, Asia, Rest of World, Total Market), and mass spectrometry revenues by manufacturer for 2016 (%). The report provides revenue analysis and company activity in the market, such as mergers and agreements. Agilent, SCIEX, and Thermo...Published: October 7, 2016 | Price: $3,360.00 – $6,720.00
This Kalorama report, Gene Editing Markets (CRISPR-based, Zinc Finger Nuclease [ZFN], TALEN, Other), provides global Revenues and Forecast for the gene editing market by type of product including consumables, instruments, services, cell-lines, animal models. Gene editing, or changing genes at specific parts of the genome of a human, plant or animal is a topic of increasing interest. This report breaks out the gene editing market by region and also by application area including: drug discovery & development, life sciences research,...Published: May 28, 2015 | Price: $3,995.00 – $7,990.00
Cell Culture: The Market for Media, Sera and Reagents The growth in biopharmaceuticals is creating an unprecedented increase in demand for cell culture products. Biopharmaceutical products are developed from large, complex protein molecules, which require equally complex manufacturing methods and an array of analytical techniques. This Kalorama Information report, Cell Culture; The Market for Media, Sera and Reagents, analyzes the world market for media, sera and reagents and the major trends and drivers. Authored by Anne Anscomb, it is the...Published: March 26, 2015 | Price: $3,995.00 – $7,990.00
Library Preparation and Target Enrichment for Next Generation Sequencing Product Markets This report, Library Preparation and Target Enrichment for Next Generation Sequencing Product Markets is a detailed analysis of the market opportunity for this important part of next generation sequencing applications The report includes: Market Estimate and Projection for Library Preparation and Target Enrichment Market Share by Company and Competitive Situation More Than 300 Partnerships and Deals in LP/TE New Library Preparation and Target Enrichment Products Significant Trends in the...Published: October 16, 2013 | Price: $3,995.00 – $7,990.00
The effectiveness of biomarkers has made them essential to medicine, with successful products on the market and many products in development. This Kalorama Information report focuses on both the clinical biomarkers and research biomarkers in medicine. Biomarkers are physiologic, genetic or biochemical parameters that provide insight into understanding disease processes and ways that medicines can work to counteract the disease. With them, diseases are detected earlier, more effective treatments can be delivered, drug reactions reduced. An example is creatine kinase,...Published: August 15, 2013 | Price: $3,995.00 – $7,990.00
The Market for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Circulating tumor cells (CTCs) are believed to detach from primary or secondary tumors and enter the bloodstream, traveling to distant organs and forming new tumors. These cells that leave the primary tumor are able to colonize distant organs in the body and initiate the process of metastasis; however, their biology is still not entirely elucidated. Circulating tumor cells have tremendous utility in cancer research, aiding scientists in deciphering...Published: March 1, 2012 | Price: $3,500.00 – $7,590.00
In this market research report, Kalorama Information defines the current opportunity and a realistic future potential for personalized medicine in clinical testing. In addition to analysis of tests currently on the market and in development, the report profiles key competitors and discusses trends that are important for understanding this much-discussed growth area of the diagnostic industry. The concept of 'Personalized Medicine', as seen by Kalorama clinical diagnostics industry analyst Shara Rosen, is currently somewhere between dream and road to reality....Published: August 1, 2009 | Price: $3,800.00 – $7,600.00
Since the last edition of Kalorama Information's DNA Sequencing Equipment and Services report, the market has been changing in unpredictable ways as second-generation sequencers are being incrementally introduced and upgraded. On the surface, the situation has become somewhat linear and predictable, but as Kalorama Information biotech analyst Justin Saeks explains, it is actually a unique and relatively volatile situation that is not seen often with life science tools markets. Third-generation systems have the potential to completely change the market, or...Published: January 1, 2007 | Price: $3,900.00 – $7,800.00
As the biopharmaceutical market grows, so will the cell culture products market. Cell culture is a major foundation of biopharmaceutical development, bioprocessing and manufacturing. Biopharmaceutical products are developed from large, complex protein molecules, which require equally complex manufacturing methods and an array of analytical techniques. As growing cells for biopharmaceutical production is slow, expensive and complicated, optimizing cell culture development is of paramount concern to companies developing biopharmaceuticals. This report is focused on cell culture used in the research and...Published: June 1, 2005 | Price: $3,500.00 – $7,000.00
Analytical microchips continue to be among the fastest growing technology segments of the life sciences. The range of applications to which these miniature laboratories may be directed is very broad, covering fields as different as pharmaceutical development, food testing, clinical diagnostics, forensics, and environmental analysis. Moreover, while the number of such products is currently limited, the number of applications is rapidly expanding through the development of significant enabling technologies. This completely updated 2nd edition of Kalorama’s popular 2003 study thoroughly...Published: August 1, 2004 | Price: $3,500.00 – $7,000.00
This Kalorama Information report focuses on current and emerging immunomodulators for cancer. The report covers both current and emerging cancer immunomodulators in detail. The report includes statistical information for cancers by type worldwide, with special emphasis on the U.S. market. Specifically, cancers where there are current products available or are in development are profiled. These include bladder, breast, colorectal, head/neck, kidney, lung, ovarian, pancreatic, and prostate cancers, as well as leukemia, lymphoma, melanoma, multiple myeloma, and neuroblastoma. The current market...Published: June 1, 2004 | Price: $3,500.00 – $7,000.00
In 2003, the market for monoclonal antibodies in the treatment of cancer is just short of $2.8 billion and growing at a phenomenal rate. The market is fueled by leading products such as Rituxan and Herceptin; however, other products continue to demand more attention each year. This study reviews market data for the years 2001 to the present and forecasts the market to 2008, including Kalorama’s estimates of the competitive market share in 2008 based on the current pipeline and...Published: March 1, 2004 | Price: $3,500.00 – $7,000.00
Cell and tissue therapies are about to revolutionize the treatment of a number of diseases, including: organ, replacement, cartilage, skin, autoimmune diseases, diabetes, neurodegenerative diseases, cancer and cardiovascular tissue damage. Although cell therapy is not a new phenomenon, what is new is the scope and versatility of research using stem cell and tissue therapeutics, and products based on combinations of cell therapy, gene manipulation, and tissue engineering. The report provides world market projections 2002-2007, discusses market trends and issues including...